摘要
Objective： To investigated whether erythropoietin （EPO） would promote the proliferation of human cancer cell line MCF-7, Panc-1 and HepG2 so as to determine whether EPO would result a worse prognosis to the patients with malignant diseases. Methods： We examined the growth inhibitory or promotional effect of EPO to MCF-7, Panc-1 and HepG2 by MTT assay. Then we examined the cell cycle of those cancer cell lines which was cultured with EPO and without EPO by FCM. Results： The results showed there was no significant growth inhibitory or promotional effect of EPO to MCF-7, Panc-1 and HepG2. The cell cycle of those cancer cell lines cultured with EPO also has no significant different to that of those cancer cell lines cultured without EPO. Conclusion： It is concluded that EPO has no promotion effect to the cancer cell lines＇ proliferation, and maybe will not result a worse prognosis to the patients with malignant diseases.
基金
Supported by a grant from the National Natural Science Foundation of China （No. 30571798）.
